查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855381

按產品類型、應用、最終用戶、連接類型、網路架構和組件分類的5G醫療設備市場－2025-2032年全球預測

5G-enabled Medical Devices Market by Product Type, Application, End User, Connectivity Type, Network Architecture, Component - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，5G醫療設備市場規模將達到 53.8578 億美元，複合年成長率為 23.56%。

關鍵市場統計數據
基準年 2024 9.911億美元
預計年份：2025年 12.2067億美元
預測年份 2032 5,385,780,000 美元
複合年成長率 (%) 23.56%

權威導論闡述了第五代互聯技術將如何重塑整個醫療保健生態系統中的臨床設備和交付模式。

第五代無線連接的引入正在重塑臨床和非臨床環境中醫療設備的設計、交付和管理方式。本報告檢驗了確定性連接、超低延遲和高設備密度將如何催生新一代診斷、監測和治療設備，同時對網路安全、法規遵循和臨床檢驗提出新的要求。從設備製造商到醫療系統營運商和網路供應商，相關人員面臨著一個快速發展的技術和商業性環境，在這個環境中，互通性、資料完整性和病患安全是創新與監管交匯的關鍵所在。

隨著醫療服務模式不斷分散化，本地基礎設施與雲端基礎分析之間的相互作用正成為設備價值提案的核心。遠距患者管理、遠端醫療模式和智慧醫院計劃如今都依賴可預測的連接性和彈性網路架構。因此，產品藍圖正在調整，從初始設計階段就融入網路適應性、邊緣運算能力和安全遠端檢測。

引言部分概述了當前的發展動態，闡述了推動5G技術普及的關鍵技術因素和營運壓力。引言也指出了決定5G理論優勢在日常臨床工作流程中實現速度的關鍵相關人員。最後，引言部分概述了報告的範圍和分析方法，後續章節則展望了複雜的技術趨勢將如何轉化為設備製造商、醫療系統和技術合作夥伴的營運重點。

對加速臨床級連接技術普及並提高其標準的關鍵技術、監管和營運變革進行簡明分析

過去幾年，一系列變革性的變化正在加速互聯醫療設備的普及，並重塑臨床工作流程。首先，邊緣運算和分散式分析技術的成熟降低了資料擷取與臨床應用之間的摩擦，從而能夠為緊急應用場景提供決策支援。同時，私有網路和混合網路的日益普及創建了可控的連接環境，在這些環境中，延遲、吞吐量和安全參數均可有效管理，以滿足臨床級要求。

其次，無線接取技術和頻譜分配的進步，特別是毫米波和6GHz以下頻段的二合一技術，正在釋放差異化的性能優勢，這些優勢直接對應高解析度成像和連續生理監測等設備類別。這種技術多樣性正促使原始設備製造商（OEM）尋求可在非獨立組網（NSA）、獨立組網（SA）和私有5G配置下運行的模組化硬體和軟體架構。

第三，人工智慧主導的分析與更豐富的遠端檢測的融合，提升了持續監測和照護現場的臨床價值，同時也提高了人們對可解釋性、檢驗和管治的期望。監管環境和報銷途徑正在不斷調整，但發展並不均衡，迫使創新者應對不同的核准情況和支付方獎勵。最後，隨著設備的激增和邊緣運算面的擴展，網路安全威脅也在加劇。因此，安全設計實踐、零信任架構和供應鏈透明度不再是可選項，而是打入市場策略。

2025年美國關稅如何改變供應鏈策略、採購動態和醫療設備引進時間表的實用評估

對於依賴全球零件採購的醫療設備製造商而言，2025年美國關稅政策的實施已產生一系列累積效應，波及供應鏈、籌資策略和產品成本結構。依賴進口無線電模組、半導體模組和專用感測器的製造商正面臨更高的到岸成本和更長的前置作業時間，迫使他們重新調整採購流程和庫存管理。這些壓力促使製造商尋求供應商多角化、增加關鍵零件的獎勵生產，並建立策略夥伴關係關係，以緩衝未來政策變革帶來的風險。

醫療系統和醫療設備製造商 (OEM) 的採購團隊正在審查供應商契約，以鎖定價格或轉向關稅更優惠的替代供應商。由於相關人員要求對總擁有成本（包括關稅相關的波動性）進行更實質審查，臨床設備的採購週期可能會延長。從監管和認證的角度來看，將組件轉移到新的供應商和製造地可能需要新的測試和文件編制，從而延長無線整合和正在進行臨床試驗的設備開發時間。

投資者和企業策略團隊正透過加快供應鏈映射和情境規劃來應對這項挑戰，並專注於供應商集中風險和重新設計的機會，以降低對高價投入品的依賴。同時，提供私有和混合5G服務的網路營運商和整合商也在調整其商業模式，以因應設備客戶採購的不確定性。最終結果是，在部署5G醫療技術的過程中，策略韌性、靈活的架構設計和供應商關係成為至關重要的競爭優勢。

全面而全面的細分分析，展示了產品類型、應用、最終用戶、連接方式、架構和組件如何影響策略和設計。

細分市場揭示了不同設備類別、應用領域、最終用戶、連接類型、網路架構和組件堆疊如何影響採用模式和產品設計優先順序。按產品類型分類，診斷設備包括影像設備、實驗室設備和照護現場診斷設備。影像設備進一步細分為CT掃描儀、MRI掃描儀和超音波診斷設備，實驗室設備則細分為血液分析儀和尿液分析儀。監測設備包括心臟監測、血糖監測、呼吸監測和生命徵象監測。心臟監測分為家用和醫院用，血糖監測分為連續監測和間歇監測，呼吸監測涵蓋睡眠呼吸中止症和肺活量測定，生命徵象監測包括血壓、心率和體溫。治療設備包括輸液幫浦、胰島素幫浦、神經刺激設備和呼吸治療設備。輸液泵分為胰島素輸注泵和鎮痛輸注泵，胰島素泵又分為貼片式和導管式，神經刺激設備分為深層腦部刺激器和脊髓刺激設備，呼吸治療設備分為持續性正壓呼吸器（CPAP）機和人工呼吸器。

應用細分將解決方案分為資產追蹤、緊急應變、遠端患者監護、智慧醫院和遠端醫療等。資產追蹤分為設備追蹤和供應鏈監控，後者又細分為設備定位和穿戴式資產追蹤；供應鏈監控則分為低溫運輸監控和庫存視覺化。緊急應變包括救護車服務和災害管理，後者進一步細分為移動診斷和院前遠距遠端保健；災害管理則分為野戰醫院支援和遠端協調。遠端患者監護進一步細分為慢性病管理、老年護理和術後護理，其中慢性病管理又細分為心臟護理和糖尿病管理；老年護理側重於活動監測和跌倒檢測；術後護理側重於疼痛和傷口監測。智慧醫院的應用案例包括資產管理、即時定位服務和人員管理，其中資產管理側重於設備追蹤和庫存管理；即時定位服務區分資產追蹤和患者追蹤；人員管理側重於人員追蹤和工作流程最佳化。遠端醫療包括緊急遠距會診、視訊諮詢和虛擬ICU。緊急遠距會診分為救護車遠端醫療和災難遠端醫療。視訊會診專注於人工智慧輔助診斷和即時高清影片，而虛擬重症監護室則專注於警報管理和遠端監控。

最終用戶細分市場涵蓋門診手術中心、診所、家庭醫療保健機構、醫院和遠端醫療提供者。門診手術中心分為醫院附屬機構和獨立機構，診所又分為門診診所和專科診所。家庭醫療保健機構分為患者家中和養老院。醫院分為私立醫院和公立醫院，遠端醫療提供者分為平台提供者和服務聚合商。依連接類型分類，細分市場包括非獨立網路（NSA）、私有5G和獨立網路（SA），其中NSA和SA分別涵蓋毫米波和6GHz以下頻段，私有5G又分為園區網路和工業網路。按網路架構分類，細分市場包括混合網路、私有網路和公用網路，其中混合架構強調邊緣整合和本地核心選項，私有網路分為園區網路和企業網路，公有網路涵蓋行動虛擬網路營運商（MVNO）和營運商管理模式。組件細分市場則明確了硬體、服務和軟體需求。硬體涵蓋天線、模組和感測器；模組又分為連接方式和電源兩種類型；服務包括諮詢、整合和編配；軟體則涵蓋分析套件、行動應用和編配。這種層級式的細分觀點有助於明確每種產品和應用場景類別中設計權衡、商業化策略和臨床檢驗工作的重點方向。

戰略區域概覽闡述了美洲、歐洲、中東和非洲以及亞太地區各自不同的採用促進因素和部署重點。

區域動態將顯著影響5G醫療設備的技術採納曲線、監管環境和商業夥伴關係。在美洲，醫療系統和設備製造商正致力於快速試驗支援網路連線的解決方案，這主要得益於學術醫療中心所進行的私人網路試點計畫以及對遠端醫療和遠端患者監護的強勁需求。北美買家越來越重視網路安全和合規途徑，而支付方也越來越青睞能夠大幅降低急診醫療服務利用率的設備。該地區的採購週期傾向於能夠展現清晰的臨床和營運投資回報率的整合解決方案，設備原始設備製造商 (OEM) 與大型網路供應商之間的夥伴關係也十分普遍，旨在降低實施風險。

監管協調和跨境互通性是歐洲、中東和非洲的核心主題。歐盟的監管架構和各國醫療保健體系推動著技術和臨床標準的製定，並高度重視能夠證明其符合多司法管轄區標準的設備。在中東，對智慧醫院基礎設施和專用網路部署的快速投資正在創造一種先行者環境，而非洲部分地區則為低頻寬、高彈性的連接模式提供了獨特的機遇，這些模式優先考慮成本效益高的遠端醫療和供應鏈可視性。在整個全部區域，官民合作關係和聯盟模式經常加速基礎設施部署和臨床試驗。

亞太地區兼具先進的製造能力和積極的數位醫療應用。該地區多個市場在民用5G部署和大規模智慧醫院專案方面處於領先地位，人工智慧診斷和高通量成像設備的整合也呈現出強勁的發展勢頭。同時，不同的報銷模式和分散的臨床採購管道要求供應商根據不同國家調整打入市場策略。供應鏈韌性是該地區的戰略重點，製造商需要在接近性零件生態系統的同時，兼顧降低關稅和地緣政治動盪的影響。總而言之，各地區的概況表明，醫療設備開發商必須使其產品策略與該地區獨特的監管、報銷和基礎設施實際情況相適應，才能加速產品普及和規模化應用。

對生態系中供應商、整合商和軟體合作夥伴的競爭角色、夥伴關係模式和策略要務進行深入剖析。

5G醫療設備領域的競爭格局正由眾多參與者共同塑造，包括設備OEM廠商、網路營運商、雲端和分析服務供應商、系統整合商以及專業軟體供應商。設備OEM廠商正在擴展產品系列，納入嵌入式連接和邊緣運算功能，並日益加強與通訊提供者和整合商的合作，以在臨床環境中檢驗端到端解決方案。網路營運商和專用網路專家則將託管連接和保障服務定位為臨床解決方案體係不可或缺的一部分，提供針對醫療保健應用場景量身定做的服務等級協定和互通性保證。

雲端和分析供應商提供可擴展的運算和人工智慧能力，加速將原始遙測數據轉化為臨床可操作的洞察；系統整合商在設備互通性、臨床工作流程整合和現場部署遠端檢測發揮關鍵作用。專注於設備管理、行動應用和分析平台的軟體開發人員在資料標準化、設備生命週期管理和法規文件方面擁有豐富的專業知識。新興企業和利基編配通常會開發一些專業功能，例如低功耗遙測模組和用於診斷的可解釋人工智慧。

對市場相關人員而言，策略要務包括透過嚴格的檢驗來證明其臨床效用，確保安全且審核的資料流，以及建立符合支付方獎勵的商業模式。結合臨床可靠性、網路保障和雲端原生分析的夥伴關係往往能夠確保早期部署，而垂直整合模式則可能在優先考慮單一供應商責任制的採購環境中提供快速上市的優勢。對許多組織而言，實現規模化的關鍵在於靈活的聯盟模式，這種模式能夠平衡專有創新與可互通的、基於標準的架構。

為製造商、醫療系統和技術合作夥伴提供一套切實可行的、優先排序的建議，以加速安全、可擴展的部署。

計劃將5G醫療設備實用化的領導者應優先考慮一系列具體可行的策略，使技術能力與臨床和商業性目標保持一致。首先，從產品早期設計到上市後監測，都應融入安全設計原則和零信任架構，以降低網路風險並滿足監管要求。儘早投資硬體模組化和軟體定義無線電，可使產品能夠在非獨立組網、獨立組網和專用網路配置下運行，從而降低重新設計成本並加快部署準備。

其次，我們建立多元化的供應商關係和區域製造方案，以應對關稅和地緣政治衝擊帶來的風險。基於情境的供應鏈建模和多源採購策略確保產品快速上市，同時減少對單一來源的依賴。我們不僅驗證了設備的精準性，還驗證了端到端遠端檢測的可靠性以及近即時決策支援的臨床應用價值。第四，我們與網路供應商、系統整合商和分析供應商建立務實的商業夥伴關係，提供滿足尋求整合化課責買家需求的捆綁式解決方案。

第五，積極與監管機構和支付方溝通，制定能夠認永續監測、遠端醫療和邊緣分析價值的報銷和合規框架。與醫療系統開展合作試驗計畫，可以為推廣應用和報銷提供強力的證據。最後，投資於員工團隊建設——包括產品團隊和客戶支援部門——使組織能夠管理複雜的混合部署，提供快速響應的現場支持，並將技術性能轉化為臨床醫生的價值提案。

對多方法研究途徑，該方法結合了初步訪談、技術檢驗、供應鏈映射和情境分析。

本研究採用多方法研究策略，旨在從技術、臨床和商業性角度對5G醫療設備進行三角驗證。主要質性研究包括對臨床負責人、設備工程師、網路專家和採購主管進行結構化訪談，以了解實際部署經驗和痛點。專家小組驗證了有關無線電波傳播、邊緣運算部署和互通性限制的技術假設。次要研究涵蓋標準化文件、監管指南、技術白皮書和公開案例研究，並基於既定實踐和近期部署情況進行檢驗。

技術檢驗包括建立效能測試場景，將設備頻寬和延遲需求對應到非獨立組網 (NSA)、獨立組網 (SA) 和私有 5G 配置。架構建模探索了本地核心網路、混合邊緣整合和公共網路依賴之間的權衡。供應鏈映射識別了因資費波動導致的組件集中風險和潛在的緩解策略。整合涉及應用場景分析，探索在不同的監管、經濟和基礎設施條件下的替代部署路徑。

本調查方法的限制包括不同司法管轄區的監管時間表各異以及商業部署速度不一，這可能會影響個案案例研究的普遍適用性。為克服這些局限性，研究結果已通過多個專家小組和技術代表進行了交叉檢驗。本調查方法強調假設的透明度，並提供了從經驗輸入到分析結論的清晰可追溯性，從而為讀者制定策略決策奠定了堅實的基礎。

簡潔的結論強調了將5G技術能力轉化為臨床價值和永續商業性優勢的關鍵優先事項。

將可靠的 5G 連線引入醫療設備，為重塑臨床工作流程、擴展遠距醫療模式以及提高診斷和治療性介入的準確性提供了變革性的機會。要充分發揮此潛力，需要設備製造商、網路供應商、醫療系統、監管機構和支付方通力合作，協調產品設計、連接保障、臨床檢驗和商業性獎勵。無論產品類型或應用領域為何，通用在於：確定性的效能、安全且審核的資料處理，以及將連接性作為設備固有屬性而非附加屬性而實現的、可驗證的臨床價值。

應對關稅和供應鏈中斷的策略韌性如今已成為企業競爭的必然要求，迫使企業重新評估其採購、製造地和合作夥伴策略。不同地區的市場接受動態差異凸顯了監理策略和市場推廣執行在地化的必要性。擁有模組化產品架構、可靠的臨床證據和靈活的商業模式的企業將更有利於擴大部署規模，並與醫療系統建立長期夥伴關係。

總而言之，5G醫療設備實現真正影響的路徑清晰明確：在設計之初就融入連接性和安全性，嚴格檢驗臨床和營運效能，並制定適應不斷變化的監管環境和採購環境的供應鏈和夥伴關係策略。積極落實這些優先事項的相關人員能夠加速將技術能力轉化為醫療服務和營運效率的可衡量改進。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將5G連線整合到遠端患者監護穿戴裝置中，以實現即時資料傳輸。
  • 在農村診所部署支援5G的超音波探頭，以支援高清移動成像
  • 利用網路切片技術在醫院5G網路中優先處理關鍵病患資料流量
  • 開發一種超低延遲的5G手術機器人，該機器人能夠進行遠端手術並提供觸覺回饋。
  • 引入基於 5G 的人工智慧演算法，用於醫院醫療設備的預測性維護
  • 整合基於 5G 的遠端用藥解決方案，以支援護理機構的遠端用藥管理。
  • 它利用 5G 連線安全地將連續的患者生物特徵資料傳輸到雲端基礎的分析平台。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：按產品類型分類的5G醫療設備市場

  • 診斷設備
    • 影像診斷
      • CT掃描儀
      • 核磁共振掃描儀
      • 超音波設備
    • 臨床實驗室診斷
      • 血液分析儀
      • 尿液分析儀
    • 照護現場診斷
  • 監測設備
    • 心臟監測
      • 居家心臟監測
      • 醫院心臟監測
    • 血糖監測
      • 定期血糖監測
      • 間歇性血糖監測
    • 呼吸監測
      • 睡眠呼吸中止監測
      • 肺活量測定監測
    • 生命徵象監測
      • 血壓監測
      • 心率監測
      • 溫度監測
  • 治療設備
    • 點滴幫浦
      • 胰島素注射
      • 疼痛管理輸液
    • 胰島素幫浦
      • 貼片幫浦
      • 管泵
    • 神經刺激設備
      • 深層腦部刺激器
      • 脊髓刺激設備
    • 呼吸治療設備
      • 持續性氣道正壓通氣機
      • 人工呼吸器

第9章：按應用分類的5G醫療設備市場

  • 資產追蹤
    • 裝置追蹤
      • 設備定位
      • 穿戴式資產追蹤
    • 供應鏈監控
      • 低溫運輸監測
      • 庫存可見性
  • 緊急應變
    • 救護車服務
      • 移動診斷
      • 院前遠端保健
    • 災害管理
      • 野戰醫院的建設
      • 遠端調節
  • 遠端患者監護
    • 慢性病管理
      • 心臟護理
      • 糖尿病管理
    • 老年人醫療保健
      • 活動監測
      • 跌倒偵測
    • 術後護理
      • 疼痛管理
      • 傷口監測
  • 智慧醫院
    • 資產管理
      • 裝置追蹤
      • 庫存管理
    • 即時定位服務
      • 資產追蹤
      • 患者追蹤
    • 員工管理
      • 人員追蹤
      • 最佳化您的工作流程
  • 遠端醫療
    • 緊急遠距會診
      • 救護車遠端保健
      • 災難遠端醫療
    • 視訊諮詢
      • 人工智慧輔助診斷
      • 即時高清視訊
    • 虛擬重症監護室
      • 警報管理
      • 遠距患者監護

第10章：按最終用戶分類的5G醫療設備市場

  • 門診手術中心
    • 醫院相關
    • 獨立
  • 診所
    • 門診部
    • 專科診所
  • 家庭醫療保健
    • 患者之家
    • 老年護理機構
  • 醫院
    • 私立醫院
    • 公立醫院
  • 遠端醫療服務提供者
    • 平台提供者
    • 服務聚合器

第11章：按連接類型分類的5G醫療設備市場

  • 非獨立組網 5G
    • 毫米波
    • 6GHz以下頻段
  • 私有5G
    • 校園網路
    • 工業網路
  • 獨立組網 5G
    • 毫米波
    • 6GHz以下頻段

12. 網路架構為基礎的5G醫療設備市場

  • 混合網路
    • 邊緣整合
    • 本地部署核心
  • 私人網路
    • 校園網路
    • 企業網路
  • 公共網路
    • MVNO
    • 營運商網路

第13章：按組件分類的5G醫療設備市場

  • 硬體
    • 天線
    • 模組
      • 連接模組
      • 電源模組
    • 感應器
  • 服務
    • 諮詢服務
    • 整合服務
    • 維護服務
  • 軟體
    • 分析軟體
    • 行動應用
    • 平台

第14章：按地區分類的5G醫療設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：依組別分類的5G醫療設備市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：各國5G醫療設備市場概況

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • General Electric Company
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Medtronic plc
    • Johnson & Johnson
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • Baxter International Inc.
    • Boston Scientific Corporation
    • Samsung Electronics Co., Ltd
Product Code: MRR-AD517FAA8AD0

The 5G-enabled Medical Devices Market is projected to grow by USD 5,385.78 million at a CAGR of 23.56% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 991.10 million
Estimated Year [2025] USD 1,220.67 million
Forecast Year [2032] USD 5,385.78 million
CAGR (%) 23.56%

An authoritative introduction outlining how fifth-generation connectivity is redefining clinical devices and delivery models across healthcare ecosystems

The deployment of fifth-generation wireless connectivity is reshaping the design, delivery, and management of medical devices across clinical and non-clinical settings. This report examines how deterministic connectivity, ultra-low latency, and high device density enable new classes of diagnostic, monitoring, and therapeutic devices while imposing fresh requirements on cybersecurity, regulatory compliance, and clinical validation. Stakeholders from device manufacturers to health system operators and network providers confront a rapidly evolving technical and commercial landscape where interoperability, data integrity, and patient safety sit at the intersection of innovation and regulation.

As care delivery models continue to decentralize, the interplay between on-premise infrastructure and cloud-based analytics is becoming central to device value propositions. Remote patient management, telehealth modalities, and smart hospital initiatives now depend on predictable connectivity and resilient network architectures. Consequently, product road maps are shifting to embed network adaptability, edge compute capabilities, and secure telemetry from initial design phases.

The introduction frames current dynamics by describing the principal technological enablers and the operational pressures that drive adoption. It also identifies the core stakeholders whose choices will determine how rapidly the theoretical benefits of 5G become realized in everyday clinical workflows. Finally, the introduction outlines the report's scope and analytical approach, setting expectations for how subsequent sections translate complex technical trends into operational priorities for device manufacturers, health systems, and technology partners.

A concise analysis of the major technological, regulatory, and operational shifts that are accelerating adoption and raising the bar for clinical-grade connectivity

The last several years have seen a suite of transformative shifts that are accelerating the adoption of connected medical devices and reframing clinical workflows. First, the maturation of edge computing and distributed analytics has reduced the friction between data capture and clinical action, enabling real-time decision support for high-acuity use cases. At the same time, the expansion of private and hybrid network deployments has created controlled connectivity environments where latency, throughput, and security parameters can be managed to meet clinical grade requirements.

Second, advances in radio access technologies and spectrum allocation-particularly the dual play of mmWave and Sub6GHz bands-are unlocking differentiated performance capabilities that map directly to device classes such as high-resolution imaging and continuous physiological monitoring. This technical diversity is prompting OEMs to pursue modular hardware and software architectures that can operate across NonStandalone, Standalone, and private 5G configurations.

Third, the convergence of AI-driven analytics with richer telemetry has increased the clinical value of continuous monitoring and point-of-care diagnostics, while simultaneously raising expectations for explainability, validation, and governance. Regulatory frameworks and reimbursement pathways are adapting, but unevenly, which means innovators must navigate heterogeneous approval landscapes and payer incentives. Finally, cybersecurity threats have intensified as devices proliferate and edge compute surfaces expand. As a result, secure-by-design practices, zero-trust architectures, and supply chain transparency are no longer optional but essential components of go-to-market strategies. Collectively, these shifts are creating both new opportunities for clinical impact and heightened requirements for cross-industry collaboration.

A pragmatic assessment of how US tariff measures in 2025 have reshaped supply chain strategies, procurement dynamics, and device deployment timelines

The United States tariff environment implemented in 2025 has introduced a series of cumulative effects that ripple through supply chains, procurement strategies, and product cost structures for medical device manufacturers reliant on global component sourcing. Manufacturers that depend on foreign-produced radios, semiconductor modules, or specialized sensors are encountering elevated landed costs and longer lead times, which in turn forces reprioritization of procurement pipelines and inventory management. These pressures create incentives for diversification of suppliers, increased onshoring of critical components, and strategic partnership agreements that can buffer exposure to future policy changes.

Procurement teams within health systems and device OEMs are reassessing vendor agreements to lock in pricing or shift to alternative suppliers with more favorable tariff exposure. Clinical device procurement cycles may lengthen as contracting stakeholders require additional due diligence around total cost of ownership, including tariff-related variability. From a regulatory and certification perspective, shifting components to new suppliers or manufacturing sites necessitates renewed testing and documentation, potentially extending time-to-deployment for devices undergoing wireless integration or clinical trials.

Investors and corporate strategy teams are responding by accelerating supply chain mapping and scenario planning, focusing on supplier concentration risks and redesign opportunities that reduce dependency on tariff-exposed inputs. At the same time, network operators and integrators who provide private and hybrid 5G services are adjusting commercial models to accommodate procurement uncertainty among their device customers. The net effect is an environment where strategic resilience, flexible architecture design, and supplier relationships become decisive competitive differentiators in the rollout of 5G-enabled medical technologies.

A comprehensive and integrated segmentation analysis showing how product types, applications, end users, connectivity, architecture, and components influence strategy and design

Segmentation reveals how adoption patterns and product design priorities diverge across device classes, application domains, end users, connectivity types, network architectures, and component stacks. In product type segmentation, diagnostic devices include imaging diagnostics, laboratory diagnostics, and point-of-care diagnostics where imaging diagnostics further bifurcate into CT scanners, MRI scanners, and ultrasound devices while laboratory diagnostics separate into blood analyzers and urinalysis analyzers; these high-bandwidth, high-accuracy instruments prioritize throughput, deterministic connectivity, and secure data pipelines. Monitoring devices encompass cardiac monitoring, glucose monitoring, respiratory monitoring, and vital signs monitoring, with cardiac monitoring split into home and hospital categories, glucose monitoring differentiated between continuous and intermittent approaches, respiratory monitoring addressing sleep apnea and spirometry, and vital signs monitoring covering blood pressure, heart rate, and temperature; these monitoring segments prioritize low power consumption, continuity of telemetry, and robust edge analytics. Therapeutic devices include infusion pumps, insulin pumps, neurostimulators, and respiratory therapy devices, with infusion pumps subdivided into insulin infusion and pain management infusion, insulin pumps into patch and tubed variants, neurostimulators into deep brain and spinal cord stimulators, and respiratory therapy devices into CPAP machines and ventilators; therapeutic segments demand ultra-reliable connectivity, fail-safe behaviors, and rigorous device interoperability.

Application segmentation groups solutions across asset tracking, emergency response, remote patient monitoring, smart hospital, and telemedicine. Asset tracking separates into device tracking and supply chain monitoring where device tracking parses into equipment positioning and wearable asset tracking while supply chain monitoring splits into cold chain oversight and inventory visibility. Emergency response includes ambulance services and disaster management, with ambulance services further distinguishing mobile diagnostics and prehospital telehealth and disaster management covering field hospital enablement and remote coordination. Remote patient monitoring subdivides into chronic disease management, elderly care, and postoperative care; chronic disease management further divides into cardiac care and diabetes management, elderly care emphasizes activity monitoring and fall detection, and postoperative care focuses on pain and wound monitoring. Smart hospital use cases include asset management, real-time location services, and staff management, with asset management covering equipment tracking and inventory control, real-time location services differentiating between asset and patient tracking, and staff management addressing personnel tracking and workflow optimization. Telemedicine includes emergency teleconsultation, video consultation, and virtual ICU where emergency teleconsultation separates into ambulance telehealth and disaster telecare, video consultation benefits from AI-assisted diagnostics and real-time HD video, and virtual ICU focuses on alarm management and remote surveillance.

End-user segmentation captures ambulatory surgical centers, clinics, home healthcare, hospitals, and telehealth providers. Ambulatory surgical centers are classified as hospital-affiliated or independent while clinics differentiate outpatient and specialty clinics. Home healthcare distinguishes between patient homes and senior care facilities. Hospitals classify as private or public, and telehealth providers separate into platform providers and service aggregators. Connectivity type segmentation contrasts NonStandalone 5G, Private 5G, and Standalone 5G; NonStandalone and Standalone each extend across mmWave and Sub6GHz bands, while Private 5G distinguishes campus networks and industrial networks. Network architecture segmentation contrasts hybrid, private, and public networks where hybrid architectures emphasize edge integration and on-premise core options, private networks break down into campus and enterprise footprints, and public networks cover MVNO and operator-managed models. Component segmentation clarifies hardware, services, and software requirements; hardware covers antennas, modules, and sensors with modules split into connectivity and power variants, services encompass consulting, integration, and maintenance, and software ranges from analytics suites to mobility applications and platform orchestration. Together, these layered segmentation perspectives illuminate where design trade-offs, commercialization tactics, and clinical validation efforts must be concentrated for each product and use-case class.

A strategic regional overview explaining how Americas, Europe Middle East & Africa, and Asia-Pacific each present distinct adoption drivers and deployment priorities

Regional dynamics materially influence technology adoption curves, regulatory priorities, and commercial partnerships across the 5G-enabled medical device landscape. In the Americas, health systems and device manufacturers emphasize rapid trials of connectivity-enabled solutions, driven by a combination of private network pilots in academic medical centers and strong demand for telemedicine and remote patient monitoring. North American purchasers exhibit heightened sensitivity to cybersecurity and compliance pathways, and payers increasingly reward devices that deliver measurable reductions in acute care utilization. Procurement cycles in this region tend to favor integrated solutions that demonstrate clear clinical and operational ROI, and partnerships between device OEMs and large network providers are common to de-risk deployments.

In Europe, Middle East & Africa, regulatory harmonization and cross-border interoperability are central themes. European Union regulatory frameworks and national health systems drive technical and clinical standards, creating a premium for devices that can demonstrate multi-jurisdictional compliance. In the Middle East, rapid investments in smart hospital infrastructures and private network deployments foster early-adopter environments, while parts of Africa present unique opportunities for low-bandwidth, resilient connectivity models that prioritize cost-effective remote care and supply chain visibility. Across the region, public-private partnerships and consortium approaches frequently accelerate infrastructure deployments and clinical pilots.

Asia-Pacific exhibits a mix of advanced manufacturing capability and aggressive digital health adoption. Several markets in this region lead in private 5G deployments and large-scale smart hospital initiatives, and there is substantial momentum around integrating AI diagnostics with high-throughput imaging equipment. At the same time, variation in reimbursement models and fragmented clinical procurement channels requires vendors to tailor go-to-market strategies by country. Supply chain resilience is a strategic priority here as manufacturers balance proximity to component ecosystems with the need to mitigate tariff and geopolitical disruptions. Collectively, regional profiles underscore that device developers must align product strategies with localized regulatory, reimbursement, and infrastructure realities to accelerate adoption and scale.

An incisive review of competitive roles, partnership models, and strategic imperatives shaping providers, integrators, and software partners in the ecosystem

Competitive dynamics in the 5G-enabled medical device space are shaped by a diverse set of players including device OEMs, network operators, cloud and analytics providers, systems integrators, and specialized software vendors. Device OEMs are extending their product portfolios to incorporate embedded connectivity and edge compute capabilities, and they increasingly partner with telecom providers and integrators to validate end-to-end solutions in clinical environments. Network operators and private network specialists are positioning managed connectivity and assurance services as an integral part of clinical solution stacks, offering service-level agreements and interoperability guarantees tailored to healthcare use cases.

Cloud and analytics vendors contribute scalable compute and AI capabilities that accelerate the translation of raw telemetry into clinically actionable insights, while systems integrators play a crucial role in orchestrating device interoperability, clinical workflow integration, and onsite deployment. Software developers focusing on device management, mobility applications, and analytics platforms bring domain expertise in data normalization, device lifecycle management, and regulatory documentation. Startups and niche vendors often advance specialized capabilities-such as low-power telemetry modules or explainable AI for diagnostics-that incumbents can acquire or integrate through strategic partnerships.

Strategic imperatives for market players include demonstrating clinical utility through rigorous validation, ensuring secure and auditable data flows, and building commercial models that align with payer incentives. Partnerships that combine clinical credibility, network assurance, and cloud-native analytics tend to secure early deployments, while vertically integrated approaches may offer speed-to-market advantages in environments where procurement preferences favor single-vendor accountability. For many organizations, the path to scale lies in flexible alliance models that balance proprietary innovation with interoperable standards-based architectures.

A pragmatic set of prioritized, implementable recommendations for manufacturers, health systems, and technology partners to accelerate secure and scalable deployments

Leaders planning to capitalize on 5G-enabled medical devices should prioritize a set of concrete, actionable strategies that align technical capability with clinical and commercial objectives. First, incorporate secure-by-design principles and zero-trust architectures from initial product design through to post-market surveillance to mitigate cyber risk and satisfy regulatory expectations. Early investment in hardware modularity and software-defined radio approaches will allow products to operate across NonStandalone, Standalone, and private network configurations, reducing redesign costs and accelerating deployment readiness.

Second, establish diversified supplier relationships and regional manufacturing options to manage exposure to tariff and geopolitical shocks. Scenario-based supply chain modeling and multi-sourcing strategies will reduce single-point dependencies while preserving time-to-market. Third, develop rigorous clinical validation pathways that integrate connectivity performance as part of clinical endpoints; demonstrate not only device accuracy but also the reliability of end-to-end telemetry and the clinical impact of near-real-time decision support. Fourth, form pragmatic commercial partnerships with network providers, systems integrators, and analytics vendors to offer bundled solutions that match purchaser preferences for integrated accountability.

Fifth, engage proactively with regulators and payers to shape reimbursement and compliance frameworks that recognize the value of continuous monitoring, telemedicine, and edge analytics. Collaborative pilot programs with health systems can create compelling evidence for adoption and reimbursement. Finally, invest in workforce capabilities-both within product teams and customer support functions-so that organizations can manage complex hybrid deployments, provide rapid field support, and translate technical performance into clinician-facing value propositions.

A transparent explanation of the multi-method research approach combining primary interviews, technical validation, supply chain mapping, and scenario analysis

This research draws on a multi-method approach designed to triangulate technical, clinical, and commercial perspectives on 5G-enabled medical devices. Primary qualitative inputs included structured interviews with clinical leaders, device engineers, networking specialists, and procurement executives to capture firsthand implementation experiences and pain points. Expert panels validated technical assumptions related to radio propagation, edge compute placement, and interoperability constraints. Secondary research encompassed standards documentation, regulatory guidance, technical whitepapers, and publicly available case studies to ground the analysis in established practices and recent deployments.

Technical validation involved performance testing scenarios that map device bandwidth and latency requirements to NonStandalone, Standalone, and private 5G configurations, and architecture modeling examined trade-offs between on-premise cores, hybrid edge integration, and public network dependence. Supply chain mapping identified component concentration risks and potential mitigation strategies in the context of tariff-induced disruption. The synthesis applied scenario analysis to explore alternative adoption paths under differing regulatory, economic, and infrastructure conditions.

Limitations of the methodology include variability in regulatory timelines across jurisdictions and the pace of commercial deployments, which can affect the generalizability of individual case studies. To address these constraints, findings were cross-verified across multiple expert cohorts and technical representatives. The methodology emphasizes transparency in assumptions and provides clear traceability from empirical inputs to analytical conclusions, offering readers a robust foundation for strategic decision-making while acknowledging evolving dynamics in technology and policy.

A concise conclusion emphasizing the essential priorities for translating 5G technical capability into clinical value and sustainable commercial advantage

The introduction of reliable 5G connectivity into medical devices presents a transformative opportunity to reconfigure clinical workflows, expand remote care models, and enhance the fidelity of diagnostic and therapeutic interventions. Realizing this potential requires a coordinated response from device manufacturers, network providers, health systems, regulators, and payers that aligns product design, connectivity assurance, clinical validation, and commercial incentives. Across product types and application domains, the common threads are deterministic performance, secure and auditable data handling, and demonstrable clinical value that integrates connectivity as an intrinsic device attribute rather than an add-on.

Strategic resilience against tariff and supply chain disruptions is now a competitive necessity, prompting organizations to rethink sourcing, manufacturing footprint, and partnership strategies. Regionally differentiated adoption dynamics underscore the need for localization in regulatory strategy and go-to-market execution. Companies that combine modular product architectures, robust clinical evidence, and flexible commercial models will be best positioned to scale deployments and secure long-term partnerships with health systems.

In sum, the pathway to impact for 5G-enabled medical devices is clear: embed connectivity and security into design, validate clinical and operational performance rigorously, and pursue adaptive supply chain and partnership strategies that align with evolving regulatory and procurement landscapes. Stakeholders that act decisively on these priorities can accelerate the translation of technical capability into measurable improvements in care delivery and operational efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of 5G connectivity in remote patient monitoring wearables for real-time data transmission
  • 5.2. Deployment of 5G-enabled ultrasound probes to support high-definition mobile imaging in rural clinics
  • 5.3. Adoption of network slicing for prioritizing critical patient data traffic in hospital 5G networks
  • 5.4. Development of ultra-low latency 5G surgical robots to enable remote telesurgery with haptic feedback
  • 5.5. Implementation of 5G-powered AI algorithms for predictive maintenance of in-hospital medical equipment
  • 5.6. Integration of 5G-enabled telepharmacy solutions to support remote medication management in care homes
  • 5.7. Use of 5G connectivity to stream continuous patient biometric data securely to cloud-based analytics platforms

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. 5G-enabled Medical Devices Market, by Product Type

  • 8.1. Diagnostic Devices
    • 8.1.1. Imaging Diagnostics
      • 8.1.1.1. CT Scanners
      • 8.1.1.2. MRI Scanners
      • 8.1.1.3. Ultrasound Devices
    • 8.1.2. Laboratory Diagnostics
      • 8.1.2.1. Blood Analyzer
      • 8.1.2.2. Urinalysis Analyzer
    • 8.1.3. Point Of Care Diagnostics
  • 8.2. Monitoring Devices
    • 8.2.1. Cardiac Monitoring
      • 8.2.1.1. Home Cardiac Monitoring
      • 8.2.1.2. Hospital Cardiac Monitoring
    • 8.2.2. Glucose Monitoring
      • 8.2.2.1. Continuous Glucose Monitoring
      • 8.2.2.2. Intermittent Glucose Monitoring
    • 8.2.3. Respiratory Monitoring
      • 8.2.3.1. Sleep Apnea Monitoring
      • 8.2.3.2. Spirometry Monitoring
    • 8.2.4. Vital Signs Monitoring
      • 8.2.4.1. Blood Pressure Monitoring
      • 8.2.4.2. Heart Rate Monitoring
      • 8.2.4.3. Temperature Monitoring
  • 8.3. Therapeutic Devices
    • 8.3.1. Infusion Pumps
      • 8.3.1.1. Insulin Infusion
      • 8.3.1.2. Pain Management Infusion
    • 8.3.2. Insulin Pumps
      • 8.3.2.1. Patch Pumps
      • 8.3.2.2. Tubed Pumps
    • 8.3.3. Neurostimulators
      • 8.3.3.1. Deep Brain Stimulators
      • 8.3.3.2. Spinal Cord Stimulators
    • 8.3.4. Respiratory Therapy Devices
      • 8.3.4.1. CPAP Machines
      • 8.3.4.2. Ventilators

9. 5G-enabled Medical Devices Market, by Application

  • 9.1. Asset Tracking
    • 9.1.1. Device Tracking
      • 9.1.1.1. Equipment Positioning
      • 9.1.1.2. Wearable Asset Tracking
    • 9.1.2. Supply Chain Monitoring
      • 9.1.2.1. Cold Chain Monitoring
      • 9.1.2.2. Inventory Visibility
  • 9.2. Emergency Response
    • 9.2.1. Ambulance Services
      • 9.2.1.1. Mobile Diagnostics
      • 9.2.1.2. Prehospital Telehealth
    • 9.2.2. Disaster Management
      • 9.2.2.1. Field Hospital Enablement
      • 9.2.2.2. Remote Coordination
  • 9.3. Remote Patient Monitoring
    • 9.3.1. Chronic Disease Management
      • 9.3.1.1. Cardiac Care
      • 9.3.1.2. Diabetes Management
    • 9.3.2. Elderly Care
      • 9.3.2.1. Activity Monitoring
      • 9.3.2.2. Fall Detection
    • 9.3.3. Postoperative Care
      • 9.3.3.1. Pain Management
      • 9.3.3.2. Wound Monitoring
  • 9.4. Smart Hospital
    • 9.4.1. Asset Management
      • 9.4.1.1. Equipment Tracking
      • 9.4.1.2. Inventory Management
    • 9.4.2. Real-Time Location Services
      • 9.4.2.1. Asset Tracking
      • 9.4.2.2. Patient Tracking
    • 9.4.3. Staff Management
      • 9.4.3.1. Personnel Tracking
      • 9.4.3.2. Workflow Optimization
  • 9.5. Telemedicine
    • 9.5.1. Emergency Teleconsultation
      • 9.5.1.1. Ambulance Telehealth
      • 9.5.1.2. Disaster Telecare
    • 9.5.2. Video Consultation
      • 9.5.2.1. AI-Assisted Diagnostics
      • 9.5.2.2. Real-Time HD Video
    • 9.5.3. Virtual ICU
      • 9.5.3.1. Alarm Management
      • 9.5.3.2. Remote Patient Surveillance

10. 5G-enabled Medical Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
    • 10.1.1. Hospital-Affiliated
    • 10.1.2. Independent
  • 10.2. Clinics
    • 10.2.1. Outpatient Clinics
    • 10.2.2. Specialty Clinics
  • 10.3. Home Healthcare
    • 10.3.1. Patient Homes
    • 10.3.2. Senior Care Facilities
  • 10.4. Hospitals
    • 10.4.1. Private Hospitals
    • 10.4.2. Public Hospitals
  • 10.5. Telehealth Providers
    • 10.5.1. Platform Providers
    • 10.5.2. Service Aggregators

11. 5G-enabled Medical Devices Market, by Connectivity Type

  • 11.1. NonStandalone 5G
    • 11.1.1. MmWave
    • 11.1.2. Sub6GHz
  • 11.2. Private 5G
    • 11.2.1. Campus Network
    • 11.2.2. Industrial Network
  • 11.3. Standalone 5G
    • 11.3.1. MmWave
    • 11.3.2. Sub6GHz

12. 5G-enabled Medical Devices Market, by Network Architecture

  • 12.1. Hybrid Network
    • 12.1.1. Edge Integrated
    • 12.1.2. On-Premise Core
  • 12.2. Private Network
    • 12.2.1. Campus Network
    • 12.2.2. Enterprise Network
  • 12.3. Public Network
    • 12.3.1. MVNO
    • 12.3.2. Operator Network

13. 5G-enabled Medical Devices Market, by Component

  • 13.1. Hardware
    • 13.1.1. Antennas
    • 13.1.2. Modules
      • 13.1.2.1. Connectivity Modules
      • 13.1.2.2. Power Modules
    • 13.1.3. Sensors
  • 13.2. Services
    • 13.2.1. Consulting Services
    • 13.2.2. Integration Services
    • 13.2.3. Maintenance Services
  • 13.3. Software
    • 13.3.1. Analytics Software
    • 13.3.2. Mobility Applications
    • 13.3.3. Platforms

14. 5G-enabled Medical Devices Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. 5G-enabled Medical Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. 5G-enabled Medical Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. General Electric Company
    • 17.3.2. Siemens Healthineers AG
    • 17.3.3. Koninklijke Philips N.V.
    • 17.3.4. Medtronic plc
    • 17.3.5. Johnson & Johnson
    • 17.3.6. Abbott Laboratories
    • 17.3.7. Becton, Dickinson and Company
    • 17.3.8. Baxter International Inc.
    • 17.3.9. Boston Scientific Corporation
    • 17.3.10. Samsung Electronics Co., Ltd

LIST OF FIGURES

  • FIGURE 1. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NETWORK ARCHITECTURE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NETWORK ARCHITECTURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. 5G-ENABLED MEDICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. 5G-ENABLED MEDICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. 5G-ENABLED MEDICAL DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY IMAGING DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY IMAGING DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY IMAGING DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY IMAGING DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY IMAGING DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY IMAGING DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY IMAGING DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY IMAGING DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CT SCANNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CT SCANNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CT SCANNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CT SCANNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CT SCANNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CT SCANNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MRI SCANNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MRI SCANNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MRI SCANNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MRI SCANNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MRI SCANNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MRI SCANNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY LABORATORY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY LABORATORY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD ANALYZER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD ANALYZER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD ANALYZER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD ANALYZER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD ANALYZER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD ANALYZER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY URINALYSIS ANALYZER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY URINALYSIS ANALYZER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY URINALYSIS ANALYZER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY URINALYSIS ANALYZER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY URINALYSIS ANALYZER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY URINALYSIS ANALYZER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CARDIAC MONITORING, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CARDIAC MONITORING, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CARDIAC MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CARDIAC MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CARDIAC MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CARDIAC MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CARDIAC MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CARDIAC MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOME CARDIAC MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOME CARDIAC MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOME CARDIAC MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOME CARDIAC MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOME CARDIAC MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOME CARDIAC MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOSPITAL CARDIAC MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOSPITAL CARDIAC MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOSPITAL CARDIAC MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOSPITAL CARDIAC MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOSPITAL CARDIAC MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOSPITAL CARDIAC MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITORING, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITORING, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INTERMITTENT GLUCOSE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INTERMITTENT GLUCOSE MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INTERMITTENT GLUCOSE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INTERMITTENT GLUCOSE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INTERMITTENT GLUCOSE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INTERMITTENT GLUCOSE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY MONITORING, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY MONITORING, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SLEEP APNEA MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SLEEP APNEA MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SLEEP APNEA MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SLEEP APNEA MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SLEEP APNEA MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SLEEP APNEA MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPIROMETRY MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPIROMETRY MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPIROMETRY MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPIROMETRY MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPIROMETRY MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPIROMETRY MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITORING, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITORING, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HEART RATE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HEART RATE MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HEART RATE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HEART RATE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HEART RATE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HEART RATE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TEMPERATURE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TEMPERATURE MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TEMPERATURE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TEMPERATURE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TEMPERATURE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TEMPERATURE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN INFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN INFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN INFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN INFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN INFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN INFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PAIN MANAGEMENT INFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PAIN MANAGEMENT INFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PAIN MANAGEMENT INFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PAIN MANAGEMENT INFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PAIN MANAGEMENT INFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PAIN MANAGEMENT INFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN PUMPS, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PATCH PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PATCH PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PATCH PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PATCH PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PATCH PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PATCH PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TUBED PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TUBED PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TUBED PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TUBED PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TUBED PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TUBED PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CPAP MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CPAP MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CPAP MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CPAP MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CPAP MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CPAP MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ASSET TRACKING, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ASSET TRACKING, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ASSET TRACKING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ASSET TRACKING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ASSET TRACKING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ASSET TRACKING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ASSET TRACKING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ASSET TRACKING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEVICE TRACKING, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEVICE TRACKING, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEVICE TRACKING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEVICE TRACKING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEVICE TRACKING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEVICE TRACKING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEVICE TRACKING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEVICE TRACKING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EQUIPMENT POSITIONING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EQUIPMENT POSITIONING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EQUIPMENT POSITIONING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EQUIPMENT POSITIONING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EQUIPMENT POSITIONING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EQUIPMENT POSITIONING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY WEARABLE ASSET TRACKING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY WEARABLE ASSET TRACKING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY WEARABLE ASSET TRACKING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY WEARABLE ASSET TRACKING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY WEARABLE ASSET TRACKING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY WEARABLE ASSET TRACKING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUPPLY CHAIN MONITORING, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUPPLY CHAIN MONITORING, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUPPLY CHAIN MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUPPLY CHAIN MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUPPLY CHAIN MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUPPLY CHAIN MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUPPLY CHAIN MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUPP